Shanghai Henlius Biotech, Inc. Class H (HK:2696) has released an update.
Shanghai Henlius Biotech, Inc. has announced the appointment of Mr. Yingbo Mao as the new Chief Financial Officer (CFO), effective from 1 July 2024. Mr. Mao brings over two decades of financial management expertise from prominent companies like Fosun Group and Coca-Cola (China). The board expresses their enthusiasm in welcoming Mr. Mao, who holds an MBA and is a Chinese Certified Public Account, to their leadership team.
For further insights into HK:2696 stock, check out TipRanks’ Stock Analysis page.
